This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Toolgen Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Jeong Joon Lee in CRISPR Technology.
Introduction
Jeong Joon Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of genetic engineering, particularly through his work on CRISPR technology. His innovative approach has led to advancements in genome editing and manipulation.
Latest Patents
Jeong Joon Lee holds a patent for a "Target-specific CRISPR mutant." This invention relates to an artificially engineered CRISPR/Cas9 system. More specifically, it involves an artificially engineered CRISPR enzyme that has enhanced target specificity. The application of this invention includes genome and epigenome manipulation, genome targeting, genome editing, and in vitro diagnosis.
Career Highlights
Jeong Joon Lee is associated with Toolgen Inc., a company that focuses on developing CRISPR technology for various applications. His work has positioned him as a key figure in the advancement of genetic engineering techniques.
Collaborations
Some of his notable coworkers include Joon Sun Lee and Min Hee Jung. Their collaborative efforts contribute to the innovative environment at Toolgen Inc.
Conclusion
Jeong Joon Lee's contributions to CRISPR technology exemplify the potential of genetic engineering in modern science. His work continues to influence the field and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile